蒼鷺治療公司
US ˙ NasdaqCM ˙ US4277461020

SecurityHRTX / Heron Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership303,209 shares
Latest Disclosed Value $ 394,172
Barclays Plc ownership in HRTX / Heron Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 303,209 shares of Heron Therapeutics, Inc. (US:HRTX) valued at $394,172 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 279,357 shares of Heron Therapeutics, Inc.. This represents a change in shares of 8.54% during the quarter. The current value of the position is $146,602 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (HRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

HRTX / Heron Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F HERON THERAPEUTICS COM 427746102 303,209 23,852 8.54 394 12.25 0.0001
2026-03-31 2025-09-30 13F/A-3 HERON THERAPEUTICS COM 427746102 279,357 -42,067 -13.09 352 -47.22 0.0001
2026-03-19 2025-09-30 13F/A-2 HERON THERAPEUTICS COM 427746102 218,455 -102,969 435 0.0001
2025-11-12 2025-09-30 13F HERON THERAPEUTICS COM 427746102 279,357 -42,067 352 0.0001
2026-02-27 2025-06-30 13F/A-2 HERON THERAPEUTICS COM 427746102 321,424 138,878 76.08 665 65.84 0.0002
2025-08-14 2025-06-30 13F/A-1 HERON THERAPEUTICS COM 427746102 321,424 138,878 1 0.0002
2025-08-13 2025-06-30 13F HERON THERAPEUTICS COM 427746102 321,424 138,878 1 0.0000
2026-03-17 2025-03-31 13F/A-1 HERON THERAPEUTICS COM 427746102 182,546 -58,800 -24.36 402 8.67 0.0001
2025-05-15 2025-03-31 13F HERON THERAPEUTICS COM 427746102 182,546 -58,800 0 0.0001
2026-03-19 2024-12-31 13F/A-1 HERON THERAPEUTICS COM 427746102 241,346 22,891 10.48 369 -14.98 0.0001
2025-02-13 2024-12-31 13F HERON THERAPEUTICS COM 427746102 241,346 22,891 0 0.0001
2026-03-31 2024-09-30 13F/A-2 HERON THERAPEUTICS COM 427746102 218,455 50,109 29.77 435 -26.32 0.0001
2024-11-19 2024-09-30 13F/A-1 HERON THERAPEUTICS COM 427746102 218,455 50,109 0 0.0001
2024-11-15 2024-09-30 13F HERON THERAPEUTICS COM 427746102 218,455 50,109 0 0.0000
2026-03-23 2024-06-30 13F/A-1 HERON THERAPEUTICS COM 427746102 168,346 31,887 23.37 589 56.23 0.0002
2024-08-14 2024-06-30 13F HERON THERAPEUTICS COM 427746102 168,346 31,887 1 0.0002
2026-03-24 2024-03-31 13F/A-1 HERON THERAPEUTICS COM 427746102 136,459 -42,295 -23.66 378 24.42 0.0001
2024-05-15 2024-03-31 13F HERON THERAPEUTICS COM 427746102 136,459 -42,295 0 0.0001
2026-03-25 2023-12-31 13F/A-1 HERON THERAPEUTICS COM 427746102 178,754 124,044 226.73 304 441.07 0.0001
2024-02-15 2023-12-31 13F HERON THERAPEUTICS COM 427746102 178,754 124,044 0 0.0001
2026-03-26 2023-09-30 13F/A-1 HERON THERAPEUTICS COM 427746102 54,710 -2,523 -4.41 56 -15.15 0.0000
2023-11-07 2023-09-30 13F HERON THERAPEUTICS COM 427746102 54,710 -2,523 0 0.0000
2026-03-30 2023-06-30 13F/A-2 HERON THERAPEUTICS COM 427746102 57,233 -41,700 -42.15 66 -55.70 0.0000
2023-09-20 2023-06-30 13F/A-1 HERON THERAPEUTICS COM 427746102 57,233 -41,700 0 0.0000
2023-08-03 2023-06-30 13F HERON THERAPEUTICS COM 427746102 57,233 -41,700 0 0.0000
2026-03-30 2023-03-31 13F/A-1 HERON THERAPEUTICS COM 427746102 98,933 24,314 32.58 149 -19.89 0.0001
2023-05-04 2023-03-31 13F HERON THERAPEUTICS COM 427746102 98,933 24,314 0 0.0001
2026-03-30 2022-12-31 13F/A-1 HERON THERAPEUTICS COM 427746102 74,619 -351,735 -82.50 187 -89.66 0.0001
2023-02-13 2022-12-31 13F HERON THERAPEUTICS COM 427746102 74,619 -351,735 0 0.0001
2022-11-03 2022-09-30 13F HERON THERAPEUTICS COM 427746102 426,354 288,093 208.37 1,799 367.27 0.0020
2022-08-12 2022-06-30 13F HERON THERAPEUTICS COM 427746102 138,261 -1,050 -0.75 385 -51.69 0.0002
2022-05-16 2022-03-31 13F HERON THERAPEUTICS COM 427746102 139,311 -2,553 -1.80 797 -38.46 0.0006
2022-02-23 2021-12-31 13F/A-1 HERON THERAPEUTICS COM 427746102 141,864 55,786 64.81 1,295 40.61 0.0005
2022-02-14 2021-12-31 13F HERON THERAPEUTICS COM 427746102 141,864 55,786 1,295 0.0001
2021-11-09 2021-09-30 13F HERON THERAPEUTICS COM 427746102 86,078 43,159 100.56 921 38.29 0.0004
2021-08-13 2021-06-30 13F HERON THERAPEUTICS COM 427746102 42,919 -95,707 -69.04 666 -70.37 0.0003
2021-05-13 2021-03-31 13F HERON THERAPEUTICS COM 427746102 138,626 70,775 104.31 2,248 56.55 0.0012
2021-02-11 2020-12-31 13F HERON THERAPEUTICS COM 427746102 67,851 -3,485 -4.89 1,436 35.86 0.0008
2020-11-12 2020-09-30 13F HERON THERAPEUTICS COM 427746102 71,336 2,542 3.70 1,057 4.34 0.0006
2020-08-12 2020-06-30 13F HERON THERAPEUTICS COM 427746102 68,794 25,337 58.30 1,013 98.24 0.0008
2020-05-13 2020-03-31 13F HERON THERAPEUTICS COM 427746102 43,457 -44,813 -50.77 511 -75.36 0.0004
2020-02-10 2019-12-31 13F HERON THERAPEUTICS COM 427746102 88,270 -6,184 -6.55 2,074 18.65 0.0012
2019-11-15 2019-09-30 13F/A-1 HERON THERAPEUTICS COM 427746102 94,454 44,722 89.93 1,748 89.18 0.0011
2019-11-14 2019-09-30 13F HERON THERAPEUTICS COM 427746102 94,454 44,722 1,748 404.1396
2019-08-14 2019-06-30 13F HERON THERAPEUTICS COM 427746102 49,732 11,053 28.58 924 -2.22 0.0006
2019-05-15 2019-03-31 13F HERON THERAPEUTICS COM 427746102 38,679 12,686 48.81 945 40.21 0.0007
2019-02-14 2018-12-31 13F HERON THERAPEUTICS COM 427746102 25,993 -35,566 -57.78 674 -65.40 0.0005
2018-11-14 2018-09-30 13F HERON THERAPEUTICS COM 427746102 61,559 53,320 647.17 1,948 508.75 0.0013
2018-08-14 2018-06-30 13F HERON THERAPEUTICS COM 427746102 8,239 -22,159 -72.90 320 -61.86 0.0003
2018-05-15 2018-03-31 13F HERON THERAPEUTICS COM 427746102 30,398 18,792 161.92 839 299.52 0.0006
2018-02-14 2017-12-31 13F HERON THERAPEUTICS COM 427746102 11,606 -17,185 -59.69 210 -54.84 0.0002
2017-11-14 2017-09-30 13F HERON THERAPEUTICS COM 427746102 28,791 23,426 436.64 465 528.38 0.0005
2017-08-14 2017-06-30 13F HERON THERAPEUTICS COM 427746102 5,365 3,456 181.04 74 155.17 0.0001
2017-05-15 2017-03-31 13F HERON THERAPEUTICS COM 427746102 1,909 -10,429 -84.53 29 -82.10 0.0000
2017-02-14 2016-12-31 13F HERON THERAPEUTICS COM 427746102 12,338 11,715 1,880.42 162 1,520.00 0.0002
2016-11-14 2016-09-30 13F HERON THERAPEUTICS COM 427746102 623 -30,282 -97.98 10 -98.21 0.0000
2016-08-12 2016-06-30 13F HERON THERAPEUTICS COM 427746102 30,905 22,199 254.99 558 255.41 0.0007
2016-05-16 2016-03-31 13F HERON THERAPEUTICS COM 427746102 8,706 3,818 78.11 157 23.62 0.0002
2016-02-12 2015-12-31 13F HERON THERAPEUTICS COM 427746102 4,888 4,520 1,228.26 127 1,311.11 0.0002
2015-11-13 2015-09-30 13F HERON THERAPEUTICS COM 427746102 368 -153 -29.37 9 -47.06 0.0000
2015-08-14 2015-06-30 13F HERON THERAPEUTICS COM 427746102 521 -183 -25.99 17 54.55 0.0000
2015-05-19 2015-03-31 13F/A-1 HERON THERAPEUTICS COM 427746102 704 -1,188 -62.79 11 -42.11 0.0000
2015-05-14 2015-03-31 13F HERON THERAPEUTICS COM 427746102 704 11
2015-02-13 2014-12-31 13F HERON THERAPEUTICS COM 427746102 1,892 1,127 147.32 19 216.67 0.0000
2014-11-14 2014-09-30 13F HERON THERAPEUTICS COM 427746102 765 -160 -17.30 6 -45.45 0.0000
2014-08-14 2014-06-30 13F HERON THERAPEUTICS COM 427746102 925 925 11 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-13 2020-03-31 13F HERON THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F HERON THERAPEUTICS OPT Call 1,300 550.00 31 675.00 n/a n/a n/a
2019-11-15 2019-09-30 13F/A HERON THERAPEUTICS OPT Call 200 4 n/a n/a n/a
2019-11-14 2019-09-30 13F HERON THERAPEUTICS OPT Call 200 4 n/a n/a n/a
2019-05-15 2019-03-31 13F HERON THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F HERON THERAPEUTICS OPT Call 9,300 -80.82 241 -84.30 n/a n/a n/a
2018-11-14 2018-09-30 13F HERON THERAPEUTICS OPT Call 48,500 850.98 1,535 675.25 n/a n/a n/a
2018-08-14 2018-06-30 13F HERON THERAPEUTICS OPT Call 5,100 750.00 198 1,064.71 n/a n/a n/a
2018-05-15 2018-03-31 13F HERON THERAPEUTICS OPT Call 600 -82.35 17 -72.58 n/a n/a n/a
2018-02-14 2017-12-31 13F HERON THERAPEUTICS OPT Call 3,400 126.67 62 158.33 n/a n/a n/a
2017-11-14 2017-09-30 13F HERON THERAPEUTICS OPT Call 1,500 50.00 24 71.43 n/a n/a n/a
2017-08-14 2017-06-30 13F HERON THERAPEUTICS OPT Call 1,000 0.00 14 -6.67 n/a n/a n/a
2017-05-15 2017-03-31 13F HERON THERAPEUTICS OPT Call 1,000 15 n/a n/a n/a
2015-11-13 2015-09-30 13F HERON THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F HERON THERAPEUTICS OPT Call 180,000 5,580 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-15 2019-03-31 13F HERON THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F HERON THERAPEUTICS OPT Put 200 -99.50 5 -99.61 n/a n/a n/a
2018-11-14 2018-09-30 13F HERON THERAPEUTICS OPT Put 40,000 166.67 1,266 117.15 n/a n/a n/a
2018-08-14 2018-06-30 13F HERON THERAPEUTICS OPT Put 15,000 -84.66 583 -78.40 n/a n/a n/a
2018-05-15 2018-03-31 13F HERON THERAPEUTICS OPT Put 97,800 2,699 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.